Reports
Global Farm Animal Drugs Market: Snapshot
Drugs occupy a key role in maintaining the health of farm animal drugs and in improving the economics for farm producers. The need for better productivity has become important more than ever for populations look for nutritious and disease-free food products. These pharmacologically active compounds have also helped prevent passing of diseases from animals to humans. Farm animals whose health has been considerably shaped by the use of drugs are ruminants, swine, equine, and poultry. Key product types in the farm animal drugs market are anti-infective, parasiticides, anasthetics, analgesics, and hormone related products.
However, the use of drugs in farm animals also poses a few risk factors, which is calling for their judicious use in food animals in various parts of the world. A case in point is the emergence of antibiotic-resistant microorganisms in animals. In developed countries, particularly in the U.S., the use of antibiotics has been banned-- continued efforts to antibiotic stewardship underscore the point. Several regulations have such trends into consideration, and have shaped the contours of the farm animal drugs market.
Global Farm Animal Drugs Market: Growth Dynamics
Over the years, growing demand for fresh meat, especially due to their protein content, is a key factor driving the demand or farm animal drugs market. Growing awareness about common infections affecting food animals in Europe and Asia Pacific has reinforced the prospects considerably. The global farm animal drugs market is witnessing robust fillip from continuously expanding livestock in numerous countries of Asia and Europe. Growing awareness of the diagnosis and treatment of bird flu and avian influenza is boosting the market.
In several of the key markets, veterinarians have benefitted from growing investments of farm producers in anti-infective agents. The growing body of research in drug development has opened new approaches in disease prevention strategies.
The farm animal drugs market is witnessing new growth trajectories from mounting concerns for the ill-health effects of antibiotic resistance on humans. This has been a recurrent concern in animal agriculture for quite some time. Numerous publications, notably by the US Food and Drug Administration, have reiterated such concerns.
Growing use of drugs for managing pain in farm animals is also a significant factor propelling lucrative avenues in the market. Growing role of vaccines on livestock health is also opening new potential in the farm animal drugs market.
Global Farm Animal Drugs Market: Notable Developments
Over the past few years, the shift has moved from benefits of drugs on the health of farm animals to food safety concern when consumed by humans. To this end, the Food and Drug Administration agency is re-evaluating "zero-day" withdrawal and milk discard times for drugs used in food animals. Broadly, this will help them know how much time elapses between the intake of drugs and when they are milked or slaughtered. Specifically, this initiative will shed light on how farmers interpret drug labels such as zero-day milk discard time. The FDA authorities through this regulation can know how many times dairy cows are milked and the time it takes to transport them from livestock shelter to slaughter house. This is helping ensure residue concentrations in edible tissues or milk from farm animals that were given drugs can be safely consumed by humans.
Such initiatives by regulatory agencies encourage favorable landscape for evolution of the arm animal drugs market.
Some of the key players in the farm animal drugs market are:
Global Farm Animal Drugs Market: Regional Analysis
Among the various key markets, North America is a prominent growth and is expected to rise at rapid pace from 2019 to 2027. A part of the growth comes from the presence of several key players in the U.S. and Canada. These players are intensively engaged in developing efficacious and safer farm animal drugs. The region has also been witnessing widespread uptake of anti-infective product.
N/A